Eric Karas serves as Executive at ARS Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Eric Karas has executed 4 insider transactions totaling $280.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2024 involved exercising options for 10,000 shares valued at $15.0K.
Eric Karas currently holds 15,693 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Karas has been a net seller of SPRY stock. They have purchased $0 and sold $280.0K worth of shares.
Eric Karas's most recent insider trade was on Sep 18, 2024, when they sold 10,000 shares at $1.50 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Planned |
| Aug 19, 2024 | SPRY | $140.0K | Sale | 10,000 | $14.00 | Planned |
| Aug 19, 2024 | SPRY | $15.0K | Option Exercise | 10,000 | $1.50 | Planned |